Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows from Operating Activities:
Net income	$ 16,557	$ 11,451
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,587	2,507
Deferred income tax benefit- net	(1,900)
Provision for bad debts	(38)	(300)
Stock issued for costs and expenses	2,239
Compensatory element of stock issuances	$ 27
Stock option exercised	2
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	$ (4,476)	(3,674)
Notes receivable	12	17
Costs and estimated earnings in excess of Billings on uncompleted contracts	(649)	403
Inventories	(596)	(43)
Prepaid expenses and other current assets	(278)	9
Other assets	223	(143)
Increase (decrease) in operating liabilities, net:
Accounts payable	(72)	(437)
Other current liabilities	(4,008)	576
Customer advances	(181)	(427)
Billings in excess of costs and estimated earnings on completed contracts	(182)	112
Other liabilities	178	249
Due to related medical practices	(17)
Net cash provided by operating activities	9,428	10,300
Cash Flows from Investing Activities:
Purchases of property and equipment	(1,774)	(534)
Cost of patents	(122)	(65)
Net cash used in investing activities	(1,896)	(599)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(3,431)	(1,871)
Distributions to noncontrolling interests	(4,972)	(4,138)
Proceeds received from acquisition - net	88
Repayment of notes receivable from employee stockholders	5	6
Net cash used in financing activities	(8,310)	(6,003)
Net (Decrease) Increase in Cash and Cash Equivalents	(778)	3,698
Cash and Cash Equivalents - Beginning of Period	8,528	9,449
Cash and Cash Equivalents - End of Period	$ 7,750	$ 13,147